DRUG
NASDAQ HealthcareBright Minds Biosciences Inc. - common stock
Biotechnology
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
�� 市场数据
| 价格 | $89.90 |
|---|---|
| 成交量 | 114,683 |
| 市值 | 879.87M |
| 贝塔系数 | -0.110 |
| RSI（14日） | 80.2 超买 |
| 200日均线 | $63.17 |
| 50日均线 | $78.71 |
| 52周最高 | $123.75 |
| 52周最低 | $23.18 |
| Forward P/E | -11.61 |
| Price / Book | 10.77 |
🎯 投资策略评分
DRUG 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (72/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🚀 Moon Shot (2/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 DRUG in your text
粘贴任何文章、记录或帖子 — 工具将提取 DRUG 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.